Clinical Trial Update: Cryoablation Combined with Anti-PD-1 Antibody in Patients with Advanced Intrahepatic Cholangiocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cryoablation in combination with an anti-PD-1 antibody for advanced intrahepatic cholangiocarcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• Anti-PD-1 antibody
• Cryoablation

Snippet

Sponsor: Fudan University | Conditions: Intrahepatic Cholangiocarcinoma | Phase 2 | Status: RECRUITING